Related Experiment Video
Updated: May 16, 2025

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
Published on: April 14, 2014
MOGAD optic neuritis after mild head/orbital trauma in six children
Alexander J Sandweiss1, Jonathan Rosen1, Chaitanya Aduru1
1Department of Pediatrics, Section of Neurology and Developmental Neuroscience, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States of America.
Abstract:
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a potential cause of optic neuritis (ON). Its triggers and etiologies are not completely understood. We describe a novel clinical observation in six young patients with MOGAD-ON in the setting of strikingly parallel histories of mild head/orbital trauma. This is a single-center retrospective case series of six young patients and age-matched isolated MOGAD-ON controls. We present data both individually (de-identified, only the six trauma-associated cases) and in aggregate. Averages are presented as the arithmetic mean +/- SEM. 6/27 patients with MOGAD-ON, (3/6 female), between 8 and 18 years old presented with ON 5.5 days after mild head trauma. Four patients developed ON ipsilateral to their unilateral head trauma while two developed bilateral ON following midline head trauma. All patients tested positive for serum anti-MOG antibodies upon ON workup. They all received intravenous corticosteroids with rapid improvement in symptoms (5.5 weeks to full visual recovery) and none have since relapsed. No other patients with MOGAD-ON experienced preceding head trauma, and all patients in the control group were asked about trauma upon assessment of the history. Head trauma may serve as an inciting event in the presentation and diagnosis of MOGAD-ON. This novel observation provides a potential pathophysiologic mechanism independent of infectious triggers, although we cannot determine if these patients were already predisposed towards MOGAD-ON.
Insights
Mild head trauma may trigger myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) presenting as optic neuritis (ON) in young patients. This suggests a potential non-infectious trigger for MOGAD-ON.
Area of Science:
- Neurology
- Immunology
- Ophthalmology
Background:
- Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a demyelinating condition that can cause optic neuritis (ON).
- The precise triggers and underlying causes of MOGAD are not fully understood.
- Head trauma is not typically recognized as a direct trigger for MOGAD.
Purpose of the Study:
- To investigate a potential link between mild head/orbital trauma and the onset of MOGAD-ON in young patients.
- To describe a novel clinical observation of MOGAD-ON following head trauma.
Main Methods:
- A single-center retrospective case series comparing six young patients with MOGAD-ON following head trauma to age-matched controls with isolated MOGAD-ON.
- Data collection included patient demographics, trauma history, clinical presentation, MOGAD diagnosis, treatment, and outcomes.
Main Results:
- Six patients (8-18 years old) developed ON approximately 5.5 days after mild head trauma, all testing positive for anti-MOG antibodies.
- Four patients had unilateral ON after unilateral trauma; two had bilateral ON after midline trauma.
- All patients responded rapidly to intravenous corticosteroids, with full visual recovery within 5.5 weeks and no relapses.
Conclusions:
- Mild head trauma may act as an inciting event for MOGAD-ON in susceptible individuals.
- This finding suggests a potential non-infectious pathophysiologic mechanism for MOGAD-ON.
- Further research is needed to determine if head trauma predisposes individuals to MOGAD-ON.
More Related Videos
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
04:02Author Spotlight: Developing Precise and Clinically Relevant Models for Studying Secondary Degeneration in Traumatic Optic Neuropathy
Published on: November 29, 2024
Related Concept Videos
Glaucoma: Overview
Photoreceptors and Visual Pathways
Angle Closure Glaucoma: Treatment